TipRanks
Go Ultimate55% OFF

ARS Pharmaceuticals (SPRY) Hedge Fund Trading Activity

Trend: ▲ Hedge Funds Increased Holdings by 200.8K Shares Last Quarter

Hedge Fund Holdings in SPRY

18.00M$3.0021.00M$6.8824.00M$10.7527.00M$14.6330.00M$18.50Jul '24Jan '25Jul '25Jan '26Jul '26$3.38Stock PriceShares Held by Hedge Funds

Based on the 13F filings of 488 Hedge Funds tracked by TipRanks, as submitted to the SEC.

Hedge Fund Confidence Signal

Unlock Hedge Fund Confidence Signal

Hedge Fund Activity​

Activity
Star Ranking
Hedge fund activity
Hedge Fund ManagerStar RankingFirmActivityHolding ChangeValue Reported% of PortfolioFollow
Mark Diker hedge funds manager, Diker Management LLC,Rank 375Mark DikerDiker Management LLCAdded95.50%$524,7190.40%
BlackRock, Inc. hedge funds manager,  ,Rank BlackRock, Inc.Not Ranked Added5.97%$42,543,665<0.01%
Peter Kolchinsky hedge funds manager, RA Capital Management,Rank 456Peter KolchinskyRA Capital ManagementNot Changed0.00%$86,996,4260.76%
James E. Flynn hedge funds manager, Deerfield Management Company, LP,Rank 390James E. FlynnDeerfield Management Company, LPNot Changed0.00%$60,105,5340.63%
Chuck Royce hedge funds manager, Royce & Associates LLC,Rank 476Chuck RoyceRoyce & Associates LLCNot Changed0.00%$432,732<0.01%
Charles Davidson hedge funds manager, Wexford Capital LP,Rank 332Charles DavidsonWexford Capital LPSold Out-100.00%$00.00%

FAQ

Which hedge funds hold ARS Pharmaceuticals?
The hedge funds that hold the most shares in ARS Pharmaceuticals are BlackRock, Inc., Mark Diker and Peter Kolchinsky.
Are hedge funds buying or selling SPRY?
In the last quarter hedge funds have Increased their holdings in ARS Pharmaceuticals by 200.8K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in ARS Pharmaceuticals stock?
Warren Buffet currently does not own shares in ARS Pharmaceuticals.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here